Publications » 2011

Show per page  
Conferences
71Svalbe B.; Grinberga S.; Veinberg G.; Dambrova M.; Zvejniece L. Comparative pharmacological activity of optical isomers of phenotropil. Abstracts, 43rd Meeting of the European Brain and Behavior Society (EBBS); Sep 9, 2011 - Sep 12: Sevilla, Spain, 2011; 146.      

72Kuka J.; Makrecka M.; Vilskersts R.; Dambrova M. The cardioprotective effect of mildronate is associated with decreased CPT I-dependent fatty acid metabolism in mitochondria. British Cardiovascular Intervention Society BSCR Autumn Meeting, Mitochondria in Cardiovascular Disease: Emerging Concepts and Novel Therapeutic Targets; : London, UK, 2011; 20.      

73Makrecka M.; Kuka J.; Liepinsh E.; Dambrova M. The regulation of mitochondrial energy metabolism by L-carnitine lowering agents in ischemia-reperfusion injury. British Cardiovascular Intervention Society BSCR Autumn Meeting , Mitochondria in Cardiovascular Disease: Emerging Concepts and Novel Therapeutic Targets; : London, UK, 2011; 20.      

74Svalbe B.; Zvejniece L.; Grinberga S.; Liepinsh E.; Dambrova M. Neuroprotective action of mildronate, an inhibitor of L-carnitine biosynthesis, after acute and chronic administration in rats. Abstracts 8th World Congress of Neuroscience, International Brain Research Organization IBRO; July 14-18: D443. Florence, Italy, 2011.      

75Svalbe B.; Zvejniece L.; Liepinsh E.; Dambrova M. Acute and chronic CNS effects of mildronate, an inhibitor of L-carnitine biosynthesis. Abstracts 36th FEBS Congress, Biochemistry for Tomorow,s Medicine; June 25-30: The FEBS Journal, YSF.117. Torino, Italy, 2011; 481.      

76Skapare E.; Konrade I.; Makrecka M.; Liepins E.; Dambrova M. Measurements of the glyoxalase-1 expression and activity in blood samples of diabetic patients. Abstracts 36th FEBS Congress, Biochemistry for Tomorow,s Medicine; June 25-30: The FEBS Journal, P10.45. Torino, Italy, 2011; 188.      

77Svalbe B.; Zvejniece L.; Liepinsh E.; Dambrova M. Acute and chronic CNS effects of mildronate, an inhibitor of L-carnitine biosynthesis. 11th Young Scientist Forum, Biochemistry for Tomorrow,s Medicine; 23-25 June: Torino, Italy, 2011; 117.      

78Segal I.; Zablotskaya A.; Mishnev A.; Maiorov M.; Zablotsky D.; Blums E.; Nikolayeva V. Magnetic Nanostructures of Biological Interest containing Silyl-Model N-(2-Hydroxyethyl)tetrahydroisoquinolines. Program / Abstract Book, Sixteenth International symposium on Silicon Chemistry ISOS XVI ; August 14-18: McMaster University, Hamilton, Ontario, Canada, 2011; 242.      

79Ignatovich L.; Romanovs V.; Starkova O.; Domrachova I.; Shestakova I. New silyl(germyl)hetarylbenzimidazoles: Synthesis and Cytotoxic Activity . Program / Abstract Book , Sixteenth International symposium on Silicon Chemistry ISOS XVI; August 14-18: McMaster University, Hamilton, Ontario, Canada, 2011; 222.      

80Zablotskaya A.; Segal I.; Popelis Yu.; Grinberga S.; Shestakova I. Triorganylsiloxyalkyltetrahydro(iso) and -silaisoquinolines as novel candidates for silyl prodrugs. Program / Abstract Book, Sixteenth International symposium on Silicon Chemistry ISOS XVI; August 14-18: McMaster University, Hamilton, Ontario, Canada, 2011; 120.      

Show per page